2E. Domínguez de Villota,J. M. Mosquera,J. J. Rubio,P. Galdos,V. Díez Balda,J. L. Serna,M. I. Tomás. Association of a low serum albumin with infection and increased mortality in critically Ill patients[J] 1980,Intensive Care Medicine(1):19～22
4Matas AJ, Simmons RL, Kjellstrand CM, et al. Increased incidence of malignancy during chronic renal failureEJ]. Lancet, 1995,1(7912) : 883 -886.
5Chung C J, Huang CY, Tsai HB, et al. Sex differences in the development of malignancies among end-stage renal disease patients: a nationwide population-based follow-up study in Taiwan I J ]. PLoS One, 2012,7 (9) : e44675.
6Teschner M, Garte C, RUckle-Lanz H, et al. Incidence and spectrum of malignant disease amongdialysis patients in North Bavaria [ J ]. Dtsch Med Wochenschr, 2002,127 (47) : 2497 - 2502.
7Stewart JH, Vajdic CM, van Leeuwen MT, et al. The pattern of excess cancer in dialysis and transplantation [J]. Nephrol Dial Transplant, 2009,24(10) : 3225 - 3231.
8Pecqueux JC, Schwarz A, Dieckmann KP, et al. Cancer incidence in patients on chronic dialysis and in renal transplant recipients[ J]. Urol Int, 1990,45 ( 5 ) : 290 -292.
9Holley JL. Screening, diagnosis, and treatment of cancer in long-term dialysis patients [ J ]. Clin J Am Soc Nephrol, 2007,2 ( 3 ) : 604 - 610.
10Alexander DD, Mink P J, Adami HO, et al. Multiple myeloma: a review of the epidemiologic literature E J :. Int J Cancer, 2007,120(Suppl 12): 40-61.
